Skip to main content
Medical information Clinical review pending

Genetic Testing

PTH Gene Hypoparathyroidism Genetic Test

The PTH Gene Hypoparathyroidism NGS Genetic DNA Test identifies genetic mutations linked to hypoparathyroidism, a condition affecting calcium regulation. This test aids in diagnosis and management.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Blood sample (EDTA tube). Confirm with the laboratory before booking.
Results
Confirm with the laboratory before booking.
Preparation
No specific fasting is required, but confirm with the laboratory before booking.
Test priceKSh 40,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the PTH Gene Hypoparathyroidism Genetic Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Symptoms suggestive of hypoparathyroidism (e.g., muscle cramps, fatigue, tingling)
  • ✓Family history of hypoparathyroidism or related endocrine disorders
  • ✓Diagnosis confirmation in suspected cases
  • ✓Genetic counseling for affected families
  • ✓Understanding the underlying cause of calcium imbalance
02

In plain language

What this test helps you understand

Identifies mutations in the PTH gene associated with hypoparathyroidism, aiding in diagnosis, understanding disease mechanisms, and guiding personalized management strategies.
The PTH Gene Hypoparathyroidism NGS Genetic DNA Test uses Next Generation Sequencing (NGS) technology to examine the PTH gene. This gene plays a key role in controlling calcium levels in the body. The test is important for individuals showing signs of hypoparathyroidism, a condition where low parathyroid hormone (PTH) levels cause imbalances in calcium and phosphorus.

This test specifically looks for mutations within the PTH gene that can cause hypoparathyroidism. Analyzing your genetic information helps healthcare providers understand the root cause of the condition and develop appropriate treatment strategies.

If you experience symptoms like muscle cramps, fatigue, tingling sensations, severe bone pain, or dental problems, this test might be relevant. Individuals with a family history of hypoparathyroidism or similar endocrine conditions may also find this genetic testing beneficial.

Benefits of this test include early identification of genetic factors contributing to hypoparathyroidism, enabling personalized treatment plans. It also provides valuable information for family planning and genetic counseling, potentially leading to better symptom management and improved health outcomes.

Discuss your results with a healthcare provider for proper interpretation. Genetic counseling may be recommended to understand the implications and discuss further steps.

We have laboratory branches in major Kenyan cities like Nairobi, Mombasa, and Kisumu. Home sample collection is also available. To book the PTH Gene Hypoparathyroidism NGS Genetic DNA Test, please contact us at +254711564616.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo specific fasting is required, but confirm with the laboratory before booking.
SampleBlood sample (EDTA tube). Confirm with the laboratory before booking.
MethodologyNext Generation Sequencing (NGS) targeting the PTH gene.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test analyzes specific regions of the PTH gene. It may not detect all possible mutations, including those in non-coding regions or large structural rearrangements. Results must be interpreted in the context of clinical findings and family history. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

Hypoparathyroidism is a condition where the parathyroid glands produce too little parathyroid hormone (PTH), leading to low calcium levels in the blood.
The PTH gene provides instructions for making the parathyroid hormone, which is essential for regulating calcium and phosphorus levels in the body.
Individuals with symptoms of hypoparathyroidism, a family history of the condition, or those whose doctors suspect a genetic cause for calcium imbalance may be recommended for this test.
Results should be discussed with a healthcare provider or genetic counselor who can explain the findings in the context of your medical history and symptoms.
Insurance coverage varies. Please check with your insurance provider regarding coverage for genetic testing.
Currently, booking is done via phone or WhatsApp at +254711564616. Please contact us to schedule your test.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp